Sugi Predict

Sugi Predict / Compounds / SCHEMBL821619

SCHEMBL821619

SCHEMBL821619

FC(F)(F)O[CH]c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ NFE2L2 Q16236 4/20 0.36
▸ ESR1 P03372 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PTPN1 P18031 1/20 0.33
▸ IDO1 P14902 3/20 0.32
▸ TDO2 P48775 2/20 0.32
▸ TRPA1 O75762 1/20 0.32
▸ GRIN1 Q05586 1/20 0.31
▸ GRIN2B Q13224 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001083 0.82 PTPN1 (0.42) NFE2L2PTPN1
SCHEMBL17310916 0.78 PIM1 (0.33) ALDH1A1TSHRMAOBCYP2A6NFE2L2
SCHEMBL2723539 0.76 MAOB (0.44) ALDH1A1MAOBNFE2L2CYP1A1CYP1B1
SCHEMBL2723536 0.76 MAOB (0.44) ALDH1A1MAOBNFE2L2CYP1A1CYP1B1
SCHEMBL4973376 0.76 NFE2L2 (0.54) NFE2L2
SCHEMBL6111605 0.75 TDP1 (0.38) ALDH1A1TSHRMAOBCYP2A6NFE2L2
SCHEMBL10584866 0.74 ESR1 (0.33) ESR1
SCHEMBL11563303 0.73 KIF11 (0.39) ALDH1A1TSHRMAOBCYP2A6LMNA
SCHEMBL10585417 0.72 — —
SCHEMBL2770867 0.70 ALDH1A1 (0.37) ALDH1A1TSHRMAOBCYP2A6NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117185983-A Bisoxindole compound, preparation method thereof and application thereof in preparation of antibacterial agent 浙江工业大学 2023-12-08 — — CN claimed
CN-116023388-A Hexahydrofuran [2,3-B ] benzofuran compound, preparation thereof and application thereof in synthesis of aflatoxin B intermediate 浙江工业大学 2023-04-28 — — CN claimed
WO-2022051503-A1 METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS CALITHERA BIOSCIENCES, INC. (US) 2022-03-10 — — WO claimed
CN-113874375-A Cyclic amide compounds and methods thereof for the treatment of rabies 株式会社大分大学先端医学研究所 2021-12-31 — — CN claimed
EP-2920168-B1 HETEROCYCLIC GLUTAMINASE INHIBITORS CALITHERA BIOSCIENCES INC (US) 2021-07-21 — — EP claimed
CN-112624962-A Carbazolyl isopropanolamine derivatives with double chiral centers and preparation method and application thereof 贵州大学 2021-04-09 — — CN claimed
CN-112592335-A Carbazole isopropanol diamine compound containing 1, 2, 3-triazole and preparation method and application thereof 贵州大学 2021-04-02 — — CN claimed
WO-2020246503-A1 CYCLIC AMIDE COMPOUNDS FOR RABIES TREATMENT AND METHOD THEREOF 株式会社大分大学先端医学研究所 2020-12-10 — — WO claimed
EP-3277276-B1 METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS CALITHERA BIOSCIENCES INC (US) 2020-11-04 — — EP claimed
US-10793535-B2 Heterocyclic glutaminase inhibitors CALITHERA BIOSCIENCES, INC. (US) 2020-10-06 — — US claimed
EP-1129689-A2 Keratinous fiber dyeing composition comprising N-(2-hydroxybenzene)-carbamate or N-(2-hydroxybenzene)urea derivatives as coupling agents and process for dyeing L'OREAL (FR) 2001-09-05 — — EP claimed
WO-2001062220-A1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES COMPRISING A N-(2-HYDROBENZENE)-CARBAMATE OR A N-(2-HYDROXY-BENZENE)-UREA AND A PYRAZOLOPYRIMINE, DYEING METHODS L'OREAL (FR) 2001-08-30 — — WO claimed
EP-1066263-A1 NOVEL CATIONIC 2-ACYLAMINOPHENOLS, THEIR USE AS COUPLER FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM, AND DYEING METHODS L'OREAL (FR) 2001-01-10 — — EP claimed
EP-1066022-A1 COMPOSITIONS FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC COUPLER, NOVEL CATIONIC COUPLERS, THEIR USE FOR OXIDATION DYEING AND DYEING METHODS L'OREAL (FR) 2001-01-10 — — EP claimed
EP-1066264-A2 NOVEL CATIONIC 2-SULPHONYLAMINOPHENOLS, THEIR USE AS COUPLERS FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM AND DYEING METHODS L'OREAL (FR) 2001-01-10 — — EP claimed
EP-1066246-A1 NOVEL CATIONIC COUPLERS AND THEIR USE FOR OXIDATION DYEING L'OREAL (FR) 2001-01-10 — — EP claimed
WO-2000042979-A1 COMPOSITIONS FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC COUPLER, NOVEL CATIONIC COUPLERS, THEIR USE FOR OXIDATION DYEING AND DYEING METHODS L'OREAL (FR) 2000-07-27 — — WO claimed
WO-2000042971-A2 NOVEL CATIONIC 2-SULPHONYLAMINOPHENOLS, THEIR USE AS COUPLERS FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM AND DYEING METHODS L'OREAL (FR) 2000-07-27 — — WO claimed
WO-2000043368-A1 NOVEL CATIONIC 2-ACYLAMINOPHENOLS, THEIR USE AS COUPLER FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM, AND DYEING METHODS L'OREAL (FR) 2000-07-27 — — WO claimed
WO-2000043356-A1 NOVEL CATIONIC COUPLERS AND THEIR USE FOR OXIDATION DYEING L'OREAL (FR) 2000-07-27 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793535-B2 Heterocyclic glutaminase inhibitors GLS, GLS2, GLUL ALDH1A1 552/4885TSHR 2654/4885MAOB 1377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.